Generating AI summary…

AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge

By Siddhi Mahatole Aug 10 (Reuters) - AbCellera said on Monday its experimental menopause treatment significantly reduced the frequency and severity of hot flashes in a mid-stage trial, sending its shares up nearly 40% in early morning trading. The drug, ABCL635, is being developed for women with moderate-to-severe vasomotor symptoms, commonly known as hot flashes, associated with menopause. continue reading...